STOCK TITAN

R1 RCM Inc. - RCM STOCK NEWS

Welcome to our dedicated page for R1 RCM news (Ticker: RCM), a resource for investors and traders seeking the latest updates and insights on R1 RCM stock.

R1 RCM Inc. (NASDAQ: RCM) is a distinguished leader in the field of revenue cycle management, serving hospitals, health systems, and physician groups throughout the United States. Leveraging cutting-edge technology, R1 RCM Inc. provides comprehensive solutions designed to enhance the financial performance and patient experience for healthcare providers.

Founded with a mission to streamline healthcare operations, R1 RCM's suite of services includes end-to-end revenue cycle management, technology-driven solutions, and process workflows aimed at improving operating margins, cash flows, and overall satisfaction among patients, physicians, and staff. The company’s technology solutions seamlessly integrate with healthcare providers' existing infrastructure, resulting in sustainable improvements in net patient revenue and operational efficiency.

In recent developments, R1 RCM Inc. reported preliminary financial results for the fourth quarter of 2023, anticipating revenues between $563 to $567 million, marking a 6 to 6.5 percent increase compared to the previous year. This growth is primarily driven by double-digit increases in modular revenue, despite some delays in new client transitions and lower incentive fees. The company also anticipates an operating income of $36 to $39 million and a net loss of $8 to $10 million, with an adjusted EBITDA ranging from $163 to $166 million.

R1 recently completed the acquisition of Acclara from Providence, one of the nation’s largest health systems, establishing a 10-year partnership that is expected to significantly enhance the company’s revenue cycle services. This acquisition is projected to contribute over $625 million in revenue and approximately $185 million to adjusted EBITDA within five years.

R1 RCM's commitment to innovation is evident in its recent advancements through generative AI, and its environmental, social, and governance (ESG) efforts, which align with the United Nations Sustainable Development Goals. The company's 2023 ESG report showcases numerous achievements, underlining its dedication to responsible global citizenship and sustainable business practices.

For further information and updates, visit the company’s official website at r1rcm.com.

Rhea-AI Summary

R1 RCM Inc. will be presenting at the 2024 Bank of America Securities Health Care Conference on May 16, 2024. The company is known for providing technology-driven solutions to improve healthcare providers' patient experience and financial performance. The presentation will be available via live audio webcast on the company's Investor Relations website, with a replay option for 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
conferences
-
Rhea-AI Summary
R1 RCM Inc. (RCM) plans to release its financial results for the first quarter of 2024 on May 8, 2024. The company will host a conference call to discuss the results, inviting investors and interested parties to participate. A live webcast and call replay will be accessible on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
-
Rhea-AI Summary
R1 RCM Inc. releases its 2023 Environmental, Social, and Governance (ESG) report, highlighting its commitment to corporate responsibility and sustainability. The report showcases achievements in financial counseling services, employee recognition, community support, and environmental initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
R1 RCM Inc. forms a Special Committee to evaluate strategic alternatives in response to New Mountain Capital's filing. The company aims to enhance stockholder value through careful review and consultation with independent advisors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
none
-
Rhea-AI Summary
R1 RCM Inc. reports strong financial performance in Q4 2023 and FY 2023 with revenue growth, net income, and adjusted EBITDA improvement. The company outlines a positive outlook for 2024, expecting revenue between $2,625 million and $2,675 million, with a focus on growth, operational discipline, and technology investments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.97%
Tags
-
Rhea-AI Summary
Coliseum Capital Management, LLC expresses dissatisfaction with the offer made by New Mountain Capital, L.L.C. to acquire R1 RCM Inc. for $13.75 per share, stating it significantly undervalues the company. Coliseum supports R1 RCM's Board, management, and strategy for creating shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.14%
Tags
Rhea-AI Summary
R1 RCM Inc. (RCM) will present at the 2024 TD Cowen Healthcare Conference on March 4 and the 2024 Barclays Global Healthcare Conference on March 13. The live webcasts can be accessed on the Investor Relations section of R1's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
conferences
-
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) has been ranked number one in three Best in KLAS categories for 2024, including Ambulatory RCM Services, Government Reimbursement Services, and Underpayment Recovery Services. The company has also earned its fourth consecutive award in the Ambulatory RCM Services category. R1 has been recognized for bringing advanced automation, deep expertise, and operational performance that helped healthcare providers achieve strong financial results and enhanced patient experiences. The company's ability to integrate across multiple EHR's, maximize earned reimbursement for Medicare cost reports, and recover missed revenue opportunities make it a trusted partner in delivering comprehensive solutions that providers seek.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
none
-
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) has entered a 10-year partnership with Providence, a leading health system, to provide comprehensive revenue cycle services. The company also announced the completion of the acquisition of Acclara from Providence and plans to release its fourth-quarter and full-year 2023 financial results and 2024 outlook on February 27, 2024. The acquisition is expected to contribute more than $625 million in revenue and approximately $185 million to Adjusted EBITDA by year five of the partnership. R1 acquired Acclara for $675 million in cash and a warrant to purchase up to 12.2 million shares of R1 stock at a strike price of $10.52.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.79%
Tags
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) expects fourth quarter revenue of approximately $563 to $567 million, GAAP Operating income of $36 to $39 million, GAAP net loss of $8 to $10 million, and adjusted EBITDA of $163 to $166 million. The company anticipates a 6 to 6.5 percent increase in revenue compared to the prior year. R1 RCM will report its 2023 financial results on February 27, 2024, and will provide details on its 2024 outlook at that time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.25%
Tags

FAQ

What is the current stock price of R1 RCM (RCM)?

The current stock price of R1 RCM (RCM) is $14.31 as of November 19, 2024.

What is the market cap of R1 RCM (RCM)?

The market cap of R1 RCM (RCM) is approximately 6.0B.

What does R1 RCM Inc. do?

R1 RCM Inc. provides technology-driven revenue cycle management services to hospitals, health systems, and physician groups in the United States, enhancing financial performance and the patient experience.

What recent achievements has R1 RCM Inc. made?

R1 RCM Inc. reported a 6 to 6.5 percent increase in preliminary fourth-quarter 2023 revenues and completed the acquisition of Acclara to further enhance its service offerings.

What is the significance of the Acclara acquisition?

The acquisition of Acclara from Providence establishes a 10-year partnership expected to contribute over $625 million in revenue and approximately $185 million to adjusted EBITDA within five years.

How does R1 RCM Inc. enhance the patient experience?

R1 RCM Inc. uses scalable, technology-driven solutions that integrate with healthcare providers' infrastructure to streamline operations, improve cash flows, and enhance overall patient satisfaction.

What are the financial highlights for R1 RCM Inc. for the fourth quarter of 2023?

R1 RCM Inc. anticipates fourth-quarter revenues between $563 to $567 million, an operating income of $36 to $39 million, and adjusted EBITDA between $163 to $166 million.

How does R1 RCM Inc. contribute to sustainability?

R1 RCM Inc. is committed to sustainability and responsible global citizenship, as highlighted in its 2023 ESG report, which aligns with the United Nations Sustainable Development Goals.

Where can I find more information about R1 RCM Inc.?

You can find more information and the latest updates about R1 RCM Inc. on their official website at r1rcm.com.

What is R1 RCM Inc.'s primary source of revenue?

The majority of R1 RCM Inc.'s revenue comes from operating fees received for their comprehensive revenue cycle management services provided to health systems, hospitals, and physician groups.

What technologies does R1 RCM Inc. utilize?

R1 RCM Inc. employs advanced technology solutions, including generative AI, to enhance operational efficiency and drive sustainable improvements in healthcare revenue cycles.

What is the mission of R1 RCM Inc.?

The mission of R1 RCM Inc. is to make healthcare work better for all by transforming the financial performance and patient experience for healthcare providers through innovative technology-driven solutions.
R1 RCM Inc.

Nasdaq:RCM

RCM Rankings

RCM Stock Data

6.04B
198.59M
1.04%
86.91%
2.56%
Health Information Services
Services-management Services
Link
United States of America
MURRAY